Authors
Loading...
Findings reveal IRF5’s role in glutamine metabolism and T cell responses in experimental autoimmune encephalomyelitis, suggesting therapeutic targeting for multiple sclerosis.
Brune et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: